Pacific Biosciences (PACB)
1.2050 -0.0750 (-5.86%) 12:59 ET [NASDAQ]
1.2000 x 5821 1.2100 x 6750
Realtime by (Cboe BZX)
1.2000 x 5821 1.2100 x 6750
Realtime 1.3000 +0.0200 (+1.56%) 09:29 ET
for Thu, Mar 13th, 2025
Results
download Want to compare other data? Select Fields| Symbol | PACB | NPCE | SMLR | ||
| Company | Pacific Biosciences | Neuropace Inc | Semler Scientific | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.3000 | 10.95 | 33.32 | ||
| High | 1.3000 | 11.01 | 34.76 | ||
| Low | 1.2000 | 10.27 | 32.55 | ||
| Last | 1.2050 | 10.28 | 32.58 | ||
| Change | -0.0750 | -0.69 | -1.02 | ||
| % Change | -5.86% | -6.29% | -3.04% | ||
| Volume | 6,593,877 | 36,620 | 88,950 | ||
| 20-Day Average Volume | 13,913,725 | 349,709 | 431,391 | ||
| Previous Close | 1.2800 | 10.97 | 33.60 | ||
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.4850 | 12.25 | 41.85 | ||
| 20-Day Raw Stochastic | 0.58% | 17.39% | 3.06% | ||
| 20-Day Relative Strength | 38.96% | 39.91% | 33.11% | ||
| Weighted Alpha | -55.70 | +5.84 | -36.03 | ||
| Today's Opinion | 88% Sell | 24% Buy | 40% Sell | ||
| Previous Opinion | 88% Sell | 40% Buy | 24% Sell | ||
| Last Month's Opinion | 56% Sell | 80% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.31% since 03/06/25 | -6.98% since 03/06/25 | -9.50% since 03/06/25 | ||
| Low | 1.2000 on 03/13/25 | 9.56 on 03/11/25 | 32.00 on 03/11/25 | ||
| High | 1.4700 on 03/10/25 | 11.21 on 03/07/25 | 37.94 on 03/07/25 | ||
| 1-Month | |||||
| %Chg | -18.58% since 02/13/25 | -13.98% since 02/13/25 | -33.93% since 02/13/25 | ||
| Low | 1.2000 on 03/13/25 | 9.56 on 03/11/25 | 32.00 on 03/11/25 | ||
| High | 2.0600 on 02/14/25 | 14.39 on 02/20/25 | 53.86 on 02/19/25 | ||
| 3-Month | |||||
| %Chg | -38.52% since 12/13/24 | -5.71% since 12/13/24 | -51.36% since 12/13/24 | ||
| Low | 1.2000 on 03/13/25 | 9.56 on 03/11/25 | 32.00 on 03/11/25 | ||
| High | 2.2200 on 01/08/25 | 15.11 on 01/24/25 | 81.56 on 12/17/24 | ||
| 6-Month | |||||
| %Chg | -33.43% since 09/13/24 | +39.97% since 09/13/24 | +26.04% since 09/13/24 | ||
| Low | 1.2000 on 03/13/25 | 5.45 on 10/25/24 | 21.77 on 09/23/24 | ||
| High | 2.7200 on 11/07/24 | 15.11 on 01/24/25 | 81.56 on 12/17/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 350,546 | 357,183 | 322,442 | ||
| Shares Outstanding, K | 273,864 | 32,560 | 9,597 | ||
| Annual Sales | 154,010,000 | 79,910,000 | 56,290,000 | ||
| Annual Net Income | -308,650,000 | -27,140,000 | 40,900,000 | ||
| Last Quarter Sales | 39,220,000 | 21,470,000 | 12,410,000 | ||
| Last Quarter Net Income | 3,570,000 | -5,250,000 | 29,210,000 | ||
| 60-Month Beta | 1.86 | 2.06 | 1.33 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.20 on 02/13/25 | -0.18 on 03/04/25 | 3.41 on 02/18/25 | ||
| Latest Earnings Date | 02/13/25 | 03/04/25 | 05/06/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 6.68 | ||